Rationale And Objectives: Lymphedema represents a significant global health challenge, severely impacting patient quality of life. Lymphatic-venous Anastomosis (LVA) is commonly employed as an effective intervention for patients with lymphedema. However, existing imaging tests for localizing lymphatic vessels exhibit various limitations; Consequently, there is a need for a more effective comprehensive method that can be employed for both preoperative localization of lymphatic vessels and postoperative patency assessment.
Methods: Under local anesthesia, Contrast-enhanced Ultrasound (CEUS) was utilized to assess lymphatic vessel function and localize it prior to LVA in eight patients with refractory lymphedema following breast cancer surgery. High-frequency Ultrasound was employed for the localization of superficial vein. One-week post-surgery, CEUS was performed on all patients to assess the patency of anastomoses, and to evaluate surgical outcomes based on the number of visible patent anastomoses, anastomotic patency rates, and other indicators.
Results: Prior to surgery, 68 pooled lymphatic vessels were visualized in eight patients, six of them exhibited tortuous and dilated. Lymphatic vessels with uniform internal diameter and intact continuity were selected for preoperative localization of LVA. Postoperatively, the anastomoses were clearly visualized and demonstrated a relatively high patency rate (26/41,63.2%). The patent anastomoses underwent "spider-like" changes. The internal diameters of the collecting lymphatic vessels were narrower post-operation compared to pre-operation measurements. Furthermore, six months after surgery, the internal diameters of the collecting lymphatic vessels of the affected limbs had decreased, with the maximum reduction reaching 11 cm.
Conclusion: The cases in this study underscore the utility of CEUS in both preoperative assessment and localization of LVA and postoperative evaluation of anastomotic patency. This could represent a new technique that might supersede traditional methods such as Indocyanine Green (ICG) and become a routine assessment tool after LVA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2025.02.001 | DOI Listing |
Microsurgery
March 2025
Department of Plastic and Reconstructive Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Background: Upper extremity lymphedema (UEL) and lower extremity lymphedema (LEL) can develop as a result of lymph node dissection in the treatment of various malignancies. While emerging microsurgical interventions using lymphaticovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) show promising outcomes for patients with lymphedema, the best approach to implementing the two procedures remains to be defined. This systematic review and meta-analysis provide a comprehensive overview of published literature on the clinical improvement of extremity lymphedema in patients who undergo either LVA, VLNT, or a combined microsurgical procedure.
View Article and Find Full Text PDFSci Rep
March 2025
Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL, 60612, USA.
Edema, characterized by the accumulation of interstitial fluid, poses significant challenges in various pathological conditions. Lymphangiogenesis is critical in edema clearance, and delayed or inadequate lymphatic responses significantly hinder healing processes. However, real-time observation of dynamic changes in lymphangiogenesis during tissue repair in animal models has been challenging, leaving the mechanisms behind compensatory lymphatic activation for edema clearance largely unexplored.
View Article and Find Full Text PDFPol Merkur Lekarski
March 2025
DEPARTMENT OF CONSERVATIVE DENTISTRY WITH ENDODONTICS, MEDICAL UNIVERSITY OF SILESIA, FACULTY OF MEDICAL SCIENCE IN ZABRZE, ZABRZE, POLAND.
The amniotic membrane, which lacks blood vessels, lymphatic vessels and nerves, is a thin membrane with anti-inflammatory and anti-scarring properties. In the field of dentistry, it is primarily employed as a dressing following the removal of malignant or pre-malignant lesions, with the objective of ensuring haemostasis and the absence of allergic reactions. Furthermore, it is employed in the treatment of oro-auricular junctions, cleft palates and in guided bone regeneration, due to the presence of mesenchymal cells.
View Article and Find Full Text PDFAm J Physiol Gastrointest Liver Physiol
March 2025
Inflammation Research Network, Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Crohn's disease (CD) is a chronic inflammatory bowel disease which also encompasses significant alterations of the mesenteric lymphatic system. Whether these changes are a mere consequence of, or directly contribute to the inflammation is unknown. Here we characterized the spatial and temporal development of these events in the TNF mouse, which develops CD-like ileitis and significant mesenteric lymphatic alterations.
View Article and Find Full Text PDFMater Today Bio
April 2025
Department of Molecular Cell Biology, Amsterdam UMC Location VU, Amsterdam, the Netherlands.
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive B-cell non-Hodgkin lymphoma, often developing resistance to current treatments. Development and testing of new therapies is hampered by lack of good and models mimicking human disease. Here, we developed a lymphoma-on-chip model to investigate the tumor-supportive roles of lymph node stromal cells (LNSCs) - fibroblastic reticular cells (FRCs) and lymphatic endothelial cells (LECs) - in the DLBCL microenvironment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!